Today Oracle Health Sciences announced that its general manager, Steve Rosenberg, has been selected by PharmaVOICE magazine as one of the most inspiring people in the life sciences industry. Steve will be recognized with this prestigious award during the PharmaVOICE 100 Celebration on Thursday, September 14 in New York City.
Steve was chosen as a PharmaVOICE 100 honoree for his leadership in driving the development of new and innovative technologies that are positively impacting efficiencies in clinical research, which help pharmaceutical companies bring new drugs to market faster. With nearly 40 years in technology, and 22 years in Health Sciences technology, including his pivotal role in accelerating the adoption of Electronic Data Capture (EDC) and defining the Integrated Clinical Environment (ICE), Steve recognized both the potential value and the significant challenges in bringing the data revolution and the cloud to life sciences. From the conservative regulatory environment to the sensitive nature of introducing new treatments to humans, Steve knew it was never going to be an easy road but to Rosenberg, these challenges have made his job worthwhile.
“I have a drive to succeed and grow our business while enabling our customers to innovate on their mission to develop new medicines. The patient is waiting, and it is our job and our joy at Oracle to push innovation in technology to help our customers reach these patients faster,” said Rosenberg.
In 2014, Mr. Rosenberg was asked by the head of Oracle Industries to take on a leadership role within the company’s health sciences business, which provides the infrastructure and technology that powers everything from clinical trials to population healthcare. Since joining Oracle, he has overseen the development of innovative technologies including the launch of the company’s most recent offering, Oracle Health Sciences Clinical One Platform, an eClinical platform that unifies clinical development operations and information and reimagines how technology supports clinical trials for maximum efficiency. The company’s flagship drug safety cloud offering, Oracle Health Sciences Argus continues to lead the market, enabling drug manufacturers to make faster and better safety decisions, optimize their global compliance and manage risk.
“Steve is a true change agent whose insights and commitment to technology innovations is helping to bring more life-saving therapies to market faster. His early understanding of the data revolution and the cloud in Life Sciences has enabled him to get in front of the data management challenges and create leading-edge technology to solve some of today’s most pressing issues in the eClinical space,” said Taren Grom, editor of PharmaVOICE.
This year’s distinguished honorees were nominated by thousands of PharmaVOICE readers and were selected for inclusion based on substantive accounts describing how they have inspired or motivated their colleagues, peers, and even competitors; their positive impact on patients, their organizations, and the industry at large; their innovative and game-changing strategies and thinking; their mentorship and guidance to the next generation of leaders; as well as their willingness to give their time and resources to their communities and philanthropic causes.
“It is truly an honor to be recognized for my contributions to the life sciences industry, but more importantly, for our work in bringing innovative technology to our customers, who give hope to patients who wait in the balance for new therapies that have the potential to save their lives or deliver a better quality of life,” Rosenberg went on to say.
The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service (PaaS) and Infrastructure as a Service (IaaS) from data centers throughout the Americas, Europe, and Asia. For more information about Oracle, please visit us at oracle.com
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.